[DER-00262E] DermaRite® Bordered Gauze Sterile Island Dressing | 4" x 4"
[ETH-1667G] Ethilon™ Nylon Sutures Size 4–0 | 18” | PS-2 | 3/8 Circle Black

Ryanodex® Dantrolene Sodium 250 mg Injection 5 mL | SDV

EAG-42367054032
https://www.613med.com/web/image/product.template/12397/image_1920?unique=bc209ca

Eagle Pharmaceuticals

5,847.00 5847.0 USD 5,847.00 (Per unit price)

6,878.82

Not Available For Sale

  • Brand
  • Type
  • Strength
  • Volume
  • Packaging
  • Active Ingredients
  • Additional
  • Manufacturer

This combination does not exist.

  • RX License on File Required to Order

    Detail
Antispasmodics

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

  • Product Description: Ryanodex® Dantrolene Sodium Injection is a highly concentrated, fast-acting medication designed for emergency treatment of malignant hyperthermia (MH) in surgical and critical care settings. Each vial contains 250 mg of dantrolene sodium, an agent that works directly on skeletal muscle cells to inhibit calcium release from the sarcoplasmic reticulum, effectively halting the hypermetabolic state associated with MH. This life-saving intervention prevents severe complications like muscle rigidity, rapid increase in body temperature, and potential organ damage, making it a critical addition to emergency and anesthesia care.
  • Ryanodex® is distinct for its ultra-concentrated formulation, requiring just 5 mL of sterile water for reconstitution compared to traditional dantrolene products. This reduced dilution and rapid reconstitution make Ryanodex® ideal for situations where immediate intervention is essential. The compact and easy-to-store vial allows for quicker response times, saving crucial minutes in life-threatening situations. Its administration should be managed by trained healthcare professionals familiar with MH crisis protocols.
  • Key Features:
    • High Concentration Formulation: 250 mg dantrolene sodium per 5 mL vial, allowing for fast reconstitution and delivery.
    • Life-Saving MH Intervention: Specifically formulated for the emergency treatment of malignant hyperthermia, quickly controlling symptoms and preventing complications.
    • Rapid Reconstitution: Requires only 5 mL of sterile water, enabling rapid preparation and immediate use in emergencies.
    • Compact Packaging: Easy to store in crash carts, anesthesia setups, and emergency kits for quick access.
    • Clinically Proven Effectiveness: Widely used and trusted in surgical and ICU settings for MH treatment.
  • Indications:
    • Ryanodex® is indicated for the treatment of malignant hyperthermia, an acute condition triggered by certain anesthetics and muscle relaxants.
    • Suitable for use in operating rooms, intensive care units, and emergency departments where rapid treatment of MH is critical.
  • Package Contents:
    • Each unit contains one 5 mL vial of Ryanodex® Dantrolene Sodium Injection, providing 250 mg of dantrolene sodium.


Product Image
Ryanodex® Dantrolene Sodium 250 mg Injection 5 mL | SDV

Not Available For Sale